The US Circuit Court of Appeals for the Third Circuit annuls a district court's order which certified a class of direct purchasers in a price-fixing suit in the blood reagents market (Ortho Clinical Diagnostics)

Buhart, Jacques

Previous article The US FTC reaches a record $1.2 billion proposed pay-for-delay settlement and injunctive relief restricting future similar settlements of patent infringement cases (Cephalon) Next article The US DoJ announces first criminal prosecution against a conspiracy specifically targeting e-commerce (Topkins)

8 Apr 2015

The US Circuit Court of Appeals for the Third Circuit annuls a district court’s order which certified a class of direct purchasers in a price-fixing suit in the blood reagents market (Ortho Clinical Diagnostics)

KEYWORDS

Reference

US Court of Appeals for the Third Circuit, Ortho Clinical Diagnostics, No. 12-4067, 8 April 2015

On Wednesday, April 8, 2015, the Third Circuit Court of Appeals vacated a district court’s order certifying a class of direct purchasers of blood reagents in a price-fixing suit against Ortho-Clinical Diagnostics Inc. In re Blood Reagents, case number 12-4067. Plaintiffs allege that Ortho-Clinical Diagnostic Inc. (Ortho) and a producer of blood reagents, violated Section 1 of the Sherman Act by

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Author

Jacques Buhart
McDermott Will & Emery (Paris)

France 120 contributions 61649 visits

Quotation

Jacques Buhart, The US Circuit Court of Appeals for the Third Circuit annuls a district court’s order which certified a class of direct purchasers in a price-fixing suit in the blood reagents market (Ortho Clinical Diagnostics), 8 April 2015, e-Competitions US Private Enforcement, Art. N° 93305

Visites 88